One week treatment with omeprazole, clarithromycin and tinidazole or lansoprazole, amoxicillin and metronidazole for cure of Pelicobacter pylori infection in duodenal ulcer patients

Journal of Physiology and Pharmacology

Volumn 47, Issue 1, 1996, Pages 221-228

  Sito, E ^a   Konturek, P Ch ^c   Bielanski W ^a   Kwiecien N ^a   Konturek, S J ^a   Baniukiewicz, A ^b   Iedynak, M ^b   Gabryelewicz, A ^b   Hahn, E G ^c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Amoxicillin; Clarithromycin; Gastric acid; Gastrin; Lansoprazole; Omeprazole; Proton pump inhibitor

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; TINIDAZOLE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DUODENUM ULCER; FEMALE; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; TASTE DISORDER;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; ANTITRICHOMONAL AGENTS; CLARITHROMYCIN; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; DUODENAL ULCER; FEMALE; GASTRIC ACIDITY DETERMINATION; GASTRIC MUCOSA; GASTRINS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; TINIDAZOLE;

EID: 0029864654     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1311-1315.
2. Calam J. Clinician's Guide to Helicobacter pylori. Chapman and Hall Medical, London 1966.
3. Anomyous. NIH Consesus Conference. Helicobacter pylori in peptic ulcer disease. NIH consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA 1994; 272: 65-69.
4. Matysiak-Budiuk T, Mégraud F. Helicobacter pylori in eastern European countries: what is the current status? Gut 1995; 35: 1683-1686.
5. Biclański W, Konturek SJ, Dobrzańska MJ, Sito E, Marshall BJ. Breath test in detection of Helicobacter pylori. J Physiol Pharmacol 1996; 47: 91-100.
6. Konturek SJ, Popiela T, Slowiaczek M, Bielański W. Gastric acid and pancreatic polypeptide responses to modified sham-feeding. Effects of truncal and parietal cell vagotomy. Gut 1986; 28: 280-286.
7. Konturek JW, Gillessen A, Konturek SJ, Domschke W. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on postprandial gastrin release in duodenal ulcer patients. Gut 1995; 37: 482-487.
8. Bazzoli T, Zagari RM, Fossi S et al. Efficacy and tolerability of a short term low dose triple therapy for eradication of Helicobacter pylori. Gastroenterology 1993; 104S4: A40.
9. Bazzoli F, Zagari RM, Fossi S, et al. Short-term, Low-dose triple therapy for eradication of Helicobacter pylori. Eur J Gastroentarol Hepatol 1994; 6: 773-777.
10. Moayyedi P, Axon ATR. Efficacy of a new one week triple therapy regime in eradicating Helicobacter pylori. Gut 1994; 35 (suppl 1): F248.
11. Labenz J, Stolte M, Ruhl GH et al. One-week low-dose triple therapy for eradication of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995; 7: 8-11.
12. Deltenre M, Jones C, Otero J et al. Strategies for Helicobacter pylori eradication in 1995. A review of international and Belgium experience. J Physiol Pharmacol 1996; 47: (in press).
13. Lind T, Veldhuywen van Zanten SJO, Unge P. et al. The MACH 1 study: optimal one week treatment for H. pylori is defined? Gut 1995; 37 (Suppl 1): A4.
14. Pytko-Polończyk J, Konturek SJ, Karczewska W et al. Oral cavity as permament reserver of Helicobacter pylori and potential source of reinfection. J Physiol Pharmacol 1996, 47: 121-129.